Catherine Harwood

17.9k total citations · 2 hit papers
183 papers, 8.6k citations indexed

About

Catherine Harwood is a scholar working on Epidemiology, Oncology and Dermatology. According to data from OpenAlex, Catherine Harwood has authored 183 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Epidemiology, 87 papers in Oncology and 68 papers in Dermatology. Recurrent topics in Catherine Harwood's work include Nonmelanoma Skin Cancer Studies (76 papers), Cancer and Skin Lesions (35 papers) and Cutaneous Melanoma Detection and Management (32 papers). Catherine Harwood is often cited by papers focused on Nonmelanoma Skin Cancer Studies (76 papers), Cancer and Skin Lesions (35 papers) and Cutaneous Melanoma Detection and Management (32 papers). Catherine Harwood collaborates with scholars based in United Kingdom, United States and Netherlands. Catherine Harwood's co-authors include Charlotte M. Proby, Irene M. Leigh, Judith Breuer, Jane McGregor, Alan Storey, Miranda Thomas, Lawrence Banks, Karin J. Purdie, Conal M. Perrett and T. Surentheran and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

Catherine Harwood

168 papers receiving 8.4k citations

Hit Papers

Role of a p53 polymorphis... 1998 2026 2007 2016 1998 2000 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Harwood United Kingdom 49 4.8k 4.2k 2.5k 2.4k 854 183 8.6k
Charlotte M. Proby United Kingdom 50 4.2k 0.9× 2.8k 0.7× 2.5k 1.0× 1.5k 0.6× 843 1.0× 159 6.8k
Joan Guitart United States 47 2.0k 0.4× 3.0k 0.7× 3.7k 1.5× 1.6k 0.7× 1.4k 1.6× 249 7.1k
Marie‐Françoise Avril France 45 1.1k 0.2× 3.6k 0.9× 953 0.4× 2.0k 0.8× 1.5k 1.7× 161 6.2k
Rosalie Elenitsas United States 37 1.4k 0.3× 2.6k 0.6× 1.8k 0.7× 1.1k 0.4× 890 1.0× 163 4.9k
Sylvie Euvrard France 36 3.5k 0.7× 3.1k 0.7× 1.9k 0.8× 535 0.2× 511 0.6× 127 5.3k
Mariusz A. Wasik United States 55 1.3k 0.3× 4.9k 1.2× 2.0k 0.8× 3.2k 1.3× 3.4k 3.9× 187 10.4k
Wallace H. Clark United States 48 1.5k 0.3× 6.4k 1.5× 1.9k 0.7× 2.9k 1.2× 1.3k 1.6× 110 9.0k
José Luis Rodríguez‐­Peralto Spain 35 1000 0.2× 1.5k 0.4× 1.2k 0.5× 1.4k 0.6× 474 0.6× 316 4.8k
Alan Storey United Kingdom 36 2.4k 0.5× 1.8k 0.4× 394 0.2× 1.6k 0.7× 613 0.7× 74 4.5k
Michael W. Piepkorn United States 38 888 0.2× 3.3k 0.8× 907 0.4× 1.9k 0.8× 1.2k 1.4× 142 5.6k

Countries citing papers authored by Catherine Harwood

Since Specialization
Citations

This map shows the geographic impact of Catherine Harwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Harwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Harwood more than expected).

Fields of papers citing papers by Catherine Harwood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Harwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Harwood. The network helps show where Catherine Harwood may publish in the future.

Co-authorship network of co-authors of Catherine Harwood

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Harwood. A scholar is included among the top collaborators of Catherine Harwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Harwood. Catherine Harwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levell, N. J., Paul Craig, Catherine Harwood, et al.. (2025). Vulval squamous cell carcinoma: a review. Clinical and Experimental Dermatology. 51(1). 1–13.
2.
Nedelcu, Roxana, Gabriela Turcu, Alice Brînzea, et al.. (2024). Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm. American Journal of Clinical Dermatology. 26(1). 45–59.
3.
Cernova, Jeva, et al.. (2024). BI02 Severe photosensitivity complicating anti-PDL1 checkpoint inhibitor treatment: an emerging immunotherapy-related skin toxicity. British Journal of Dermatology. 191(Supplement_1). i138–i138.
4.
Patel, Ankit, Luke Gammon, Tania Maffucci, et al.. (2020). Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in Melanoma. Cancer Research. 80(12). 2676–2688. 18 indexed citations
5.
Lechertier, Tanguy, Louise E. Reynolds, Hyojin Kim, et al.. (2020). Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth. Nature Communications. 11(1). 2810–2810. 47 indexed citations
6.
Keohane, Stephen, P.G. Budny, O.M. Dolan, et al.. (2020). British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020*. British Journal of Dermatology. 184(3). 401–414. 56 indexed citations
7.
Venables, Zoe C, Tamar Nijsten, Kwok Wong, et al.. (2019). Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013–15: a cohort study. British Journal of Dermatology. 181(3). 474–482. 102 indexed citations
8.
Purdie, Karin J., Jun Wang, Catherine Harwood, et al.. (2019). A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing. International Journal of Molecular Sciences. 20(14). 3428–3428. 19 indexed citations
9.
Harwood, Catherine, et al.. (2018). A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors. Cancer Research. 78(10). 2577–2588. 14 indexed citations
10.
Lai, Kevin, Catherine Harwood, Karin J. Purdie, et al.. (2017). Genomic analysis of atypical fibroxanthoma. PLoS ONE. 12(11). e0188272–e0188272. 29 indexed citations
11.
Neale, Rachel Ε., Soenke J. Weissenborn, Damiano Abeni, et al.. (2013). Human Papillomavirus Load in Eyebrow Hair Follicles and Risk of Cutaneous Squamous Cell Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 22(4). 719–727. 78 indexed citations
12.
Harwood, Catherine, David Mesher, J.M. McGregor, et al.. (2012). A Surveillance Model for Skin Cancer in Organ Transplant Recipients: A 22-Year Prospective Study in an Ethnically Diverse Population. American Journal of Transplantation. 13(1). 119–129. 94 indexed citations
13.
Lambert, S., Catherine Harwood, Karin J. Purdie, et al.. (2011). Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene. International Journal of Cancer. 131(3). E216–26. 14 indexed citations
14.
Proby, Charlotte M., Catherine Harwood, Rachel Ε. Neale, et al.. (2011). A Case–Control Study of Betapapillomavirus Infection and Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. American Journal of Transplantation. 11(7). 1498–1508. 98 indexed citations
15.
Gulati, Abha, et al.. (2008). Magnetic resonance imaging with gadolinium enhancement in renal failure: a need for caution. International Journal of Dermatology. 47(9). 947–949. 2 indexed citations
16.
O’Shaughnessy, Ryan F.L., Baki Akgũl, Alan Storey, et al.. (2007). Cutaneous Human Papillomaviruses Down-regulate AKT1, whereas AKT2 Up-regulation and Activation Associates with Tumors. Cancer Research. 67(17). 8207–8215. 37 indexed citations
17.
Harwood, Catherine & Charlotte M. Proby. (2002). Human papillomaviruses and non-melanoma skin cancer. Current Opinion in Infectious Diseases. 15(2). 101–114. 125 indexed citations
18.
Harwood, Catherine, T. Surentheran, Jane McGregor, et al.. (2000). Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. Journal of Medical Virology. 61(3). 289–297. 334 indexed citations
19.
Rosenthal, Adam N., et al.. (1999). p53 codon 72 polymorphism and the risk of cervical cancer in UK Caucasians (abstract). UCL Discovery (University College London). 1 indexed citations
20.
Harwood, Catherine. (1995). Causes and clinical manifestations of lymphatic failure. Clinics in Dermatology. 13(5). 459–471. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026